DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

Information source: Wyeth
Information obtained from ClinicalTrials.gov on February 12, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Plaque Psoriasis

Intervention: Enbrel (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Wyeth

Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Wyeth
Trial Manager, Principal Investigator, Affiliation: MedinfoDEU@wyeth.com

Overall contact:
Trial Manager, Email: clintrialparticipation@wyeth.com

Summary

The purpose of this study is to investigate the incidences of adverse events for patients with plaque psoriasis treated with Enbrel under usual care settings.

Clinical Details

Official title: Observational Study With Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

Study design: Cohort, Prospective

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Proven diagnosis of Plaque Psoriasis

Exclusion Criteria:

- Contraindications according to SmPC of Enbrel

Locations and Contacts

Trial Manager, Email: clintrialparticipation@wyeth.com

Bonn, Nordrheim-Westfalen 53105, Germany; Recruiting
Additional Information

Starting date: April 2005
Ending date: April 2009
Last updated: December 19, 2007

Page last updated: February 12, 2009

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012